PUBLISHER: QYResearch | PRODUCT CODE: 1108354
PUBLISHER: QYResearch | PRODUCT CODE: 1108354
The global Automated Biochemical Analyzers market size was US$ 3,443.77 million in 2021 and is forecast to a readjusted size of US$ 4,645.92 million by 2028 with a CAGR of 4.17% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Floor-standing accounting for 93.48% of the Automated Biochemical Analyzers global market in 2021, is projected to value US$ 4,350.00 million by 2028, growing at a revised 4.19% CAGR from 2022 to 2028. While Hospital segment is altered to a 4.08% CAGR throughout this forecast period.
The North America Automated Biochemical Analyzers market size was US$ 1,143.51 million in 2021, while China was US$ 504.38 million. The proportion of the North America was 33.21% in 2021, while Chinese percentage was 14.65%, and it is predicted that China share will reach 15.92% in 2028, trailing a CAGR of 5.56% through the analysis period.
The global key manufacturers of Automated Biochemical Analyzers include Roche, Danaher, Siemens Healthcare, Abbott, Hitachi, Mindray Medical, Thermo Scientific, KHB, Sunostik, ELITech, etc. In 2021, the global top five players occupied for a share approximately 74.76% in terms of revenue.
The global Automated Biochemical Analyzers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Automated Biochemical Analyzers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.